Cancer sequencing using next-generation sequencing (NGS) methods provides more information in less time compared to traditional single-gene and array-based approaches. With NGS, researchers can perform whole-genome studies, targeted gene profiling, tumor-normal comparisons, and more. NGS also offers the sensitivity to detect rare somatic variants, tumor subclones, and circulating DNA fragments.
See a comprehensive view of the unique mutations present in tumor tissue.Learn More
Cost-effectively identify coding variants related to tumor progression.Learn More
Focus on a set of genes with known cancer associations.Learn More
RNA sequencing can help determine which variants are expressed and affect tumor cell function.Learn More
Use the high sensitivity of NGS to detect noninvasive biomarkers, such as circulating tumor DNA.Learn More